INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
Inhaltsverzeichnis
- 927
-
Early-Stage Lung Cancer, Surgery, and Stereotactic Body Radiation Therapy: Quality of LifeVidetic, G. M. et al. | 2016
- 931
-
Transformative Technologies: The Crookes, Coolidge, and Cascade TubesAronowitz, J. N. et al. | 2016
- 934
-
Does Heavy Ion Therapy Work Through the Immune System?Durante, M. / Brenner, D. J. / Formenti, S. C. et al. | 2016
- 937
-
Results of COG ACNS0331: A Phase III Trial of Involved-Field Radiotherapy (IFRT) and Low Dose Craniospinal Irradiation (LD-CSI) with Chemotherapy in Average-Risk Medulloblastoma: A Report from the Children's Oncology GroupMichalski, J. M. / Janss, A. / Vezina, G. et al. | 2016
- 937
-
N107C/CEC.3: A Phase III Trial of Post-Operative Stereotactic Radiosurgery (SRS) Compared with Whole Brain Radiotherapy (WBRT) for Resected Metastatic Brain DiseaseBrown, P. D. / Ballman, K. V. / Cerhan, J. et al. | 2016
- 938
-
Extreme Hypofractionation versus Conventionally Fractionated Radiotherapy for Intermediate Risk Prostate Cancer: Early Toxicity Results from the Scandinavian Randomized Phase III Trial “HYPO-RT-PC”Widmark, A. / Gunnlaugsson, A. / Beckman, L. et al. | 2016
- 938
-
Treatment with 6 Cycles of CVP or R-CVP after Involved Field Radiation Therapy (IFRT) Significantly Improves Progression-free Survival Compared to IFRT alone in Stage I-II Low Grade Follicular Lymphoma: Results of an International Randomized TrialMacManus, M. P. / Fisher, R. / Roos, D. et al. | 2016
- 938
-
A Phase III, Randomized Double-Blind Study of Doxepin Rinse versus Magic Mouthwash versus Placebo in the Treatment of Acute Oral Mucositis Pain in Patients Receiving Head and Neck Radiotherapy with or without Chemotherapy (Alliance A221304)Miller, R. C. / Le-Rademacher, J. / Sio, T. T. et al. | 2016
- 939
-
Low-Risk Meningioma: Initial Outcomes from NRG Oncology/RTOG 0539Rogers, L. / Zhang, P. / Vogelbaum, M. A. et al. | 2016
- 939
-
Continued Benefit to Rectal Separation for Prostate RT: Final Results of a Phase III TrialHamstra, D. A. / Mariados, N. F. / Shah, D. K. et al. | 2016
- 940
-
Final Analysis of a Randomized Phase III Trial of Accelerated versus Conventional Fractionation Radiotherapy for Glottic Cancer of T1-2N0M0 (JCOG0701)Kodaira, T. / Kagami, Y. / Shibata, T. et al. | 2016
- 941
-
The KRAS-variant is a Biomarker of Cetuximab Response and Altered Immunity in Head and Neck Cancer: NRG Oncology/RTOG 0522Weidhaas, J. B. / Harris, J. / Schaue, D. et al. | 2016
- 941
-
NRG Oncology/RTOG 1014: 3 Year Efficacy Report From a Phase II Study of Repeat Breast Preserving Surgery and 3D Conformal Partial Breast Re-Irradiation (PBrI) for In-Breast RecurrenceArthur, D. W. / Moughan, J. / Kuerer, H. M. et al. | 2016
- 941
-
A Multicenter Phase II Study of Stereotactic Body Radiation Therapy for Hepatocellular CarcinomaJang, W. I. / Kim, M. S. / Seo, Y. S. et al. | 2016
- 942
-
Shaping the Immune Landscape in Irradiated Breast Cancer Patients with Systemic TGF-β BlockadeSchaue, D. / Xie, M. / Ratikan, J. et al. | 2016
- 943
-
Predictive Factor Analysis of Response-Adapted Radiation Therapy for Chemotherapy-Sensitive Pediatric Hodgkin Lymphoma: Analysis of the Children's Oncology Group AHOD 0031 TrialCharpentier, A. M. / Friedman, D. L. / Wolden, S. et al. | 2016
- 951
-
Does Bleomycin Lung Toxicity Increase the Risk of Radiation Pneumonitis in Hodgkin Lymphoma?Abou Yehia, Z. / Mikhaeel, G. N. / Smith, G. et al. | 2016
- 959
-
Salivary Cytokine Levels and Oral Mucositis in Head and Neck Cancer Patients Treated With Chemotherapy and Radiation TherapyBossi, P. / Bergamini, C. / Miceli, R. et al. | 2016
- 967
-
The Impact of Radiation Treatment Time on Survival in Patients With Head and Neck CancerShaikh, T. / Handorf, E. A. / Murphy, C. T. et al. | 2016
- 976
-
Multicenter Phase 2 Study of Cisplatin and 5-Fluorouracil With Concurrent Radiation Therapy as an Organ Preservation Approach in Patients With Squamous Cell Carcinoma of the Cervical EsophagusZenda, S. / Kojima, T. / Kato, K. et al. | 2016
- 985
-
Radiation Dose Escalation in Esophageal Cancer Revisited: A Contemporary Analysis of the National Cancer Data Base, 2004 to 2012Brower, J. V. / Chen, S. / Bassetti, M. F. et al. | 2016
- 994
-
Phase 1/2 Study of the Addition of Cisplatin to Adjuvant Chemotherapy With Image Guided High-Precision Radiation Therapy for Completely Resected Gastric CancerGoody, R. B. / MacKay, H. / Pitcher, B. et al. | 2016
- 1003
-
Acute Toxicity and Tumor Response in Locally Advanced Rectal Cancer After Preoperative Chemoradiation Therapy With Shortening of the Overall Treatment Time Using Intensity-Modulated Radiation Therapy With Simultaneous Integrated Boost: A Phase 2 TrialBut-Hadzic, J. / Anderluh, F. / Brecelj, E. et al. | 2016
- 1011
-
The Effect of Biologically Effective Dose and Radiation Treatment Schedule on Overall Survival in Stage I Non-Small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation TherapyStahl, J. M. / Ross, R. / Harder, E. M. et al. | 2016
- 1021
-
Stereotactic Body Radiation Therapy Boost After Concurrent Chemoradiation for Locally Advanced Non-Small Cell Lung Cancer: A Phase 1 Dose Escalation StudyHepel, J. T. / Leonard, K. L. / Safran, H. et al. | 2016
- 1028
-
Quality of Life in Long-term Survivors of Muscle-Invasive Bladder CancerMak, K. S. / Smith, A. B. / Eidelman, A. et al. | 2016
- 1037
-
Survival After Conservative Management Versus External Beam Radiation Therapy in Elderly Patients With Localized Prostate CancerDell'Oglio, P. / Boehm, K. / Trudeau, V. et al. | 2016
- 1046
-
Salvage Radiation Therapy Dose Response for Biochemical Failure of Prostate Cancer After Prostatectomy—A Multi-Institutional Observational StudyPisansky, T. M. / Agrawal, S. / Hamstra, D. A. et al. | 2016
- 1054
-
Long-Term Update of NRG Oncology RTOG 0319: A Phase 1 and 2 Trial to Evaluate 3-Dimensional Conformal Radiation Therapy Confined to the Region of the Lumpectomy Cavity for Stage I and II Breast CarcinomaRabinovitch, R. / Moughan, J. / Vicini, F. et al. | 2016
- 1060
-
Association Between Radiation Necrosis and Tumor Biology After Stereotactic Radiosurgery for Brain MetastasisMiller, J. A. / Bennett, E. E. / Xiao, R. et al. | 2016
- 1070
-
Patterns of Failure in Pediatric Rhabdomyosarcoma After Proton TherapyVern-Gross, T. Z. / Indelicato, D. J. / Bradley, J. A. et al. | 2016
- 1078
-
Simulated Online Adaptive Magnetic Resonance–Guided Stereotactic Body Radiation Therapy for the Treatment of Oligometastatic Disease of the Abdomen and Central Thorax: Characterization of Potential AdvantagesHenke, L. / Kashani, R. / Yang, D. et al. | 2016
- 1087
-
A Novel Respiratory Motion Perturbation Model Adaptable to Patient Breathing IrregularitiesYuan, A. / Wei, J. / Gaebler, C. P. et al. | 2016
- 1097
-
Reoptimization of Intensity Modulated Proton Therapy Plans Based on Linear Energy TransferUnkelbach, J. / Botas, P. / Giantsoudi, D. et al. | 2016
- 1107
-
Spot-Scanning Proton Arc (SPArc) Therapy: The First Robust and Delivery-Efficient Spot-Scanning Proton Arc TherapyDing, X. / Li, X. / Zhang, J. M. et al. | 2016
- 1117
-
Verification of Dose Distribution in Carbon Ion Radiation Therapy for Stage I Lung CancerIrie, D. / Saitoh, J. i. / Shirai, K. et al. | 2016
- 1124
-
In Reply to Fodor and Di MuzioPerrier, L. / Morelle, M. / Dussart, S. et al. | 2016
- 1124
-
In Regard to Perrier et alFodor, A. / Di Muzio, N. G. et al. | 2016
- 1126
-
In Regard to Zietman et alEgevad, L. / Samaratunga, H. / Srigley, J. R. et al. | 2016
- 1127
-
In Reply to Samaratunga et alZietman, A. / Smith, J. / Klein, E. et al. | 2016
- 1128
-
In Regard to Baumann et alLeung, J. et al. | 2016
- 1128
-
In Reply to LeungChristodouleas, J. P. / Eapen, L. J. / Baumann, B. C. et al. | 2016
- 1129
-
Erratum to: Baumann BC, Bosch WR, Bahl A, et al. Development and validation of consensus contouring guidelines for adjuvant radiation therapy for bladder cancer after radical cystectomy. Int J Radiat Oncol Biol Phys 2016;96:78-86.| 2016
- 1129
-
In Reply to Tini et alKubicek, G. J. / Patel, A. et al. | 2016
- 1130
-
Meetings| 2016
- A13
-
Issue Highlights| 2016